Metraipolis › archive › dc_69eba0427610

Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41091701
DOI
10.1371/journal.pone.0333341
License (as archived)
solo-consultazione
Archived
2026-11-09T07:25:19.120Z
SHA-256 of the archived text
b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe
Stable URL of this page
https://metraipolis.com/documento/dc_69eba0427610

How to cite

Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701 — Europe PMC (en), https://europepmc.org/article/MED/41091701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69eba0427610 (Metraipolis archive dc_69eba0427610, sha256 b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe)
BibTeX
@misc{dc69eba0427610,
  title = {Key outcomes in treatment of activated phosphoinositide 3-kinase delta syndrome: An e-Delphi panel study and responder threshold application — Europe PMC PMID:41091701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41091701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69eba0427610; sha256 b36e095425e7de8a43484d84bdcc8ad54bfe489b7aab26206e284d69dfa859fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41091701. Agents can read the archived copy with the MCP tool read_document.